-
1
-
-
0032505102
-
Thrombopoietin
-
Kaushansky K. Thrombopoietin. N Engl J Med 1998; 339: 746-54.
-
(1998)
N Engl J Med
, vol.339
, pp. 746-754
-
-
Kaushansky, K.1
-
2
-
-
0042914309
-
Long-term administration of pegylated recombinant human megakaryocyte growth and development factor dramatically improved cytopenias in a patient with myelodysplastic syndrome
-
Kizaki M, Miyakawa Y, Ikeda Y. Long-term administration of pegylated recombinant human megakaryocyte growth and development factor dramatically improved cytopenias in a patient with myelodysplastic syndrome. Br J Haematol 2003; 122: 764-7.
-
(2003)
Br J Haematol
, vol.122
, pp. 764-767
-
-
Kizaki, M.1
Miyakawa, Y.2
Ikeda, Y.3
-
3
-
-
38949153807
-
Historical review: Megakaryopoiesis and thrombopoiesis
-
Kaushansky K. Historical review: Megakaryopoiesis and thrombopoiesis. Blood 2008; 111: 981-6.
-
(2008)
Blood
, vol.111
, pp. 981-986
-
-
Kaushansky, K.1
-
4
-
-
34249733156
-
New thrombopoietic growth factors
-
Kuter DJ. New thrombopoietic growth factors. Blood 2007; 109: 4607-16.
-
(2007)
Blood
, vol.109
, pp. 4607-4616
-
-
Kuter, D.J.1
-
5
-
-
0036530040
-
Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor
-
Basser RL, O'Flaherty E, Green M, Edmonds M, Nichol J, Menchaca DM, Cohen B, Begley CG. Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor. Blood 2002; 99: 2599-602.
-
(2002)
Blood
, vol.99
, pp. 2599-2602
-
-
Basser, R.L.1
O'Flaherty, E.2
Green, M.3
Edmonds, M.4
Nichol, J.5
Menchaca, D.M.6
Cohen, B.7
Begley, C.G.8
-
6
-
-
0035760892
-
Thrombocytopenia caused by the development of antibodies to thrombopoietin
-
Li J, Yang C, Xia Y, Bertino A, Glaspy J, Roberts M, Kuter DJ. Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood 2001; 98: 3241-8.
-
(2001)
Blood
, vol.98
, pp. 3241-3248
-
-
Li, J.1
Yang, C.2
Xia, Y.3
Bertino, A.4
Glaspy, J.5
Roberts, M.6
Kuter, D.J.7
-
7
-
-
38349190476
-
Idiopathic thrombocytopenic purpura: Current concepts in pathophysiology and management
-
Stasi R, Evangelista ML, Stipa E, Buccisano F, Venditti A, Amadori S. Idiopathic thrombocytopenic purpura: Current concepts in pathophysiology and management. Thromb Haemost 2008; 99: 4-13.
-
(2008)
Thromb Haemost
, vol.99
, pp. 4-13
-
-
Stasi, R.1
Evangelista, M.L.2
Stipa, E.3
Buccisano, F.4
Venditti, A.5
Amadori, S.6
-
8
-
-
0037100423
-
Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura
-
Nomura S, Dan K, Hotta T, Fujimura K, Ikeda Y. Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura. Blood 2002; 100: 728-30.
-
(2002)
Blood
, vol.100
, pp. 728-730
-
-
Nomura, S.1
Dan, K.2
Hotta, T.3
Fujimura, K.4
Ikeda, Y.5
-
9
-
-
0032227226
-
Endogenous TPO (eTPO) levels in health and disease: Possible clues for therapeutic intervention
-
Nichol JL. Endogenous TPO (eTPO) levels in health and disease: Possible clues for therapeutic intervention. Stem Cells 1998; 16 (Suppl. 2): 165-75.
-
(1998)
Stem Cells
, vol.16
, Issue.SUPPL. 2
, pp. 165-175
-
-
Nichol, J.L.1
-
10
-
-
0842328846
-
Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP
-
McMillan R, Wang L, Tomer A, Nichol J, Pistillo J. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 2004; 103: 1364-9.
-
(2004)
Blood
, vol.103
, pp. 1364-1369
-
-
McMillan, R.1
Wang, L.2
Tomer, A.3
Nichol, J.4
Pistillo, J.5
-
11
-
-
33750035507
-
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP
-
Bussel JB, Kuter DJ, George JN, McMillan R, Aledort LM, Conklin GT, Lichtin AE, Lyons RM, Nieva J, Wasser JS, Wiznitzer I, Kelly R, Chen CF, Nichol JL. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med 2006; 355: 1672-81.
-
(2006)
N Engl J Med
, vol.355
, pp. 1672-1681
-
-
Bussel, J.B.1
Kuter, D.J.2
George, J.N.3
McMillan, R.4
Aledort, L.M.5
Conklin, G.T.6
Lichtin, A.E.7
Lyons, R.M.8
Nieva, J.9
Wasser, J.S.10
Wiznitzer, I.11
Kelly, R.12
Chen, C.F.13
Nichol, J.L.14
-
12
-
-
38649120593
-
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: A double-blind randomised controlled trial
-
Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JT, Bourgeois E, Guthrie TH Jr, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrère F, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: A double-blind randomised controlled trial. Lancet 2008; 371: 395-403.
-
(2008)
Lancet
, vol.371
, pp. 395-403
-
-
Kuter, D.J.1
Bussel, J.B.2
Lyons, R.M.3
Pullarkat, V.4
Gernsheimer, T.B.5
Senecal, F.M.6
Aledort, L.M.7
George, J.N.8
Kessler, C.M.9
Sanz, M.A.10
Liebman, H.A.11
Slovick, F.T.12
de Wolf, J.T.13
Bourgeois, E.14
Guthrie, T.H.15
Newland, A.16
Wasser, J.S.17
Hamburg, S.I.18
Grande, C.19
Lefrère, F.20
more..
-
13
-
-
36549001698
-
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura
-
Bussel JB, Cheng G, Saleh MN, Psaila B, Kovaleva L, Meddeb B, Kloczko J, Hassani H, Mayer B, Stone NL, Arning M, Provan D, Jenkins JM. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 2007; 357: 2237-47.
-
(2007)
N Engl J Med
, vol.357
, pp. 2237-2247
-
-
Bussel, J.B.1
Cheng, G.2
Saleh, M.N.3
Psaila, B.4
Kovaleva, L.5
Meddeb, B.6
Kloczko, J.7
Hassani, H.8
Mayer, B.9
Stone, N.L.10
Arning, M.11
Provan, D.12
Jenkins, J.M.13
-
14
-
-
60249099882
-
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: A randomised, double-blind, placebo-controlled trial
-
Bussel JB, Provan D, Shamsi T, Cheng G, Psaila B, Kovaleva L, Salama A, Jenkins JM, Roychowdhury D, Mayer B, Stone N, Arning M. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: A randomised, double-blind, placebo-controlled trial. Lancet 2009; 373: 641-8.
-
(2009)
Lancet
, vol.373
, pp. 641-648
-
-
Bussel, J.B.1
Provan, D.2
Shamsi, T.3
Cheng, G.4
Psaila, B.5
Kovaleva, L.6
Salama, A.7
Jenkins, J.M.8
Roychowdhury, D.9
Mayer, B.10
Stone, N.11
Arning, M.12
-
15
-
-
56449126654
-
Pharmacodynamics and pharmacokinetics of the novel thrombopoietin mimetic peptide RWJ-800088 in humans
-
Liem-Moolenaar M, Cerneus D, Molloy CJ, End D, Brown KH, de Kam ML, Cohen AF, van Hensbergen Y, Burggraaf J. Pharmacodynamics and pharmacokinetics of the novel thrombopoietin mimetic peptide RWJ-800088 in humans. Clin Pharmacol Ther 2008; 84: 481-7.
-
(2008)
Clin Pharmacol Ther
, vol.84
, pp. 481-487
-
-
Liem-Moolenaar, M.1
Cerneus, D.2
Molloy, C.J.3
End, D.4
Brown, K.H.5
de Kam, M.L.6
Cohen, A.F.7
van Hensbergen, Y.8
Burggraaf, J.9
-
16
-
-
34648847269
-
Single and multiple oral doses of AKR-501 (YM477) increase the platelet count in healthy volunteers
-
[ASH Annual Meeting Abstracts]
-
Desjardins RE, Tempel DL, Lucek R, Kuter DJ. Single and multiple oral doses of AKR-501 (YM477) increase the platelet count in healthy volunteers [ASH Annual Meeting Abstracts]. Blood 2006; 108: 477.
-
(2006)
Blood
, vol.108
, pp. 477
-
-
Desjardins, R.E.1
Tempel, D.L.2
Lucek, R.3
Kuter, D.J.4
-
17
-
-
67849083635
-
Clinical characterization of a novel oral thrombopoietin mimetic LGD-4665 in healthy volunteers demonstrate safe and sustained increases in platelet counts with flexible dosing choices for phase II trials
-
[ASH Annual Meeting Abstracts]
-
Dziewanowska ZE, Kapil RP, Zhang JK, Berg JK, Stevens VJ, Matsumoto RM, Greenberg L, Morris MY. Clinical characterization of a novel oral thrombopoietin mimetic LGD-4665 in healthy volunteers demonstrate safe and sustained increases in platelet counts with flexible dosing choices for phase II trials [ASH Annual Meeting Abstracts]. Blood 2008; 112: 3406.
-
(2008)
Blood
, vol.112
, pp. 3406
-
-
Dziewanowska, Z.E.1
Kapil, R.P.2
Zhang, J.K.3
Berg, J.K.4
Stevens, V.J.5
Matsumoto, R.M.6
Greenberg, L.7
Morris, M.Y.8
-
18
-
-
33744456732
-
A novel nonpeptidyl human c-Mpl activator stimulates human megakaryopoiesis and thrombopoiesis
-
Nakamura T, Miyakawa Y, Miyamura A, Yamane A, Suzuki H, Ito M, Ohnishi Y, Ishiwata N, Ikeda Y, Tsuruzoe N. A novel nonpeptidyl human c-Mpl activator stimulates human megakaryopoiesis and thrombopoiesis. Blood 2006; 107: 4300-7.
-
(2006)
Blood
, vol.107
, pp. 4300-4307
-
-
Nakamura, T.1
Miyakawa, Y.2
Miyamura, A.3
Yamane, A.4
Suzuki, H.5
Ito, M.6
Ohnishi, Y.7
Ishiwata, N.8
Ikeda, Y.9
Tsuruzoe, N.10
-
19
-
-
54349089372
-
The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis
-
Nogami W, Yoshida H, Koizumi K, Yamada H, Abe K, Arimura A, Yamane N, Takahashi K, Yamane A, Oda A, Tanaka Y, Takemoto H, Ohnishi Y, Ikeda Y, Miyakawa Y. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis. Haematologica 2008; 93: 1495-504.
-
(2008)
Haematologica
, vol.93
, pp. 1495-1504
-
-
Nogami, W.1
Yoshida, H.2
Koizumi, K.3
Yamada, H.4
Abe, K.5
Arimura, A.6
Yamane, N.7
Takahashi, K.8
Yamane, A.9
Oda, A.10
Tanaka, Y.11
Takemoto, H.12
Ohnishi, Y.13
Ikeda, Y.14
Miyakawa, Y.15
-
20
-
-
33749249751
-
A rationally designed agonist antibody fragment that functionally mimics thrombopoietin
-
Frederickson S, Renshaw MW, Lin B, Smith LM, Calveley P, Springhorn JP, Johnson K, Wang Y, Su X, Shen Y, Bowdish KS. A rationally designed agonist antibody fragment that functionally mimics thrombopoietin. Proc Natl Acad Sci USA 2006; 103: 14307-12.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 14307-14312
-
-
Frederickson, S.1
Renshaw, M.W.2
Lin, B.3
Smith, L.M.4
Calveley, P.5
Springhorn, J.P.6
Johnson, K.7
Wang, Y.8
Su, X.9
Shen, Y.10
Bowdish, K.S.11
-
21
-
-
19944429567
-
A novel therapeutic approach for thrombocytopenia by minibody agonist of the thrombopoietin receptor
-
Orita T, Tsunoda H, Yabuta N, Nakano K, Yoshino T, Hirata Y, Ohtomo T, Nezu J, Sakumoto H, Ono K, Saito M, Kumagai E, Nanami M, Kaneko A, Yoshikubo T, Tsuchiya M. A novel therapeutic approach for thrombocytopenia by minibody agonist of the thrombopoietin receptor. Blood 2005; 105: 562-6.
-
(2005)
Blood
, vol.105
, pp. 562-566
-
-
Orita, T.1
Tsunoda, H.2
Yabuta, N.3
Nakano, K.4
Yoshino, T.5
Hirata, Y.6
Ohtomo, T.7
Nezu, J.8
Sakumoto, H.9
Ono, K.10
Saito, M.11
Kumagai, E.12
Nanami, M.13
Kaneko, A.14
Yoshikubo, T.15
Tsuchiya, M.16
-
22
-
-
38949193925
-
Switching constant domains enhances agonist activities of antibodies to a thrombopoietin receptor
-
Kai M, Motoki K, Yoshida H, Emuta C, Chisaka Y, Tsuruhata K, Endo C, Muto M, Shimabe M, Nishiyama U, Hagiwara T, Matsumoto A, Miyazaki H, Kataoka S. Switching constant domains enhances agonist activities of antibodies to a thrombopoietin receptor. Nat Biotechnol 2008; 26: 209-11.
-
(2008)
Nat Biotechnol
, vol.26
, pp. 209-211
-
-
Kai, M.1
Motoki, K.2
Yoshida, H.3
Emuta, C.4
Chisaka, Y.5
Tsuruhata, K.6
Endo, C.7
Muto, M.8
Shimabe, M.9
Nishiyama, U.10
Hagiwara, T.11
Matsumoto, A.12
Miyazaki, H.13
Kataoka, S.14
-
23
-
-
0035951790
-
Thrombopoietin induces phosphoinositol 3-kinase activation through SHP2, Gab, and insulin receptor substrate proteins in BAF3 cells and primary murine megakaryocytes
-
Miyakawa Y, Rojnuckarin P, Habib T, Kaushansky K. Thrombopoietin induces phosphoinositol 3-kinase activation through SHP2, Gab, and insulin receptor substrate proteins in BAF3 cells and primary murine megakaryocytes. J Biol Chem 2001; 276: 2494-502.
-
(2001)
J Biol Chem
, vol.276
, pp. 2494-2502
-
-
Miyakawa, Y.1
Rojnuckarin, P.2
Habib, T.3
Kaushansky, K.4
-
24
-
-
31044439372
-
The molecular mechanisms that control thrombopoiesis
-
Kaushansky K. The molecular mechanisms that control thrombopoiesis. J Clin Invest 2005; 115: 3339-47.
-
(2005)
J Clin Invest
, vol.115
, pp. 3339-3347
-
-
Kaushansky, K.1
-
25
-
-
0346881171
-
AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl
-
Broudy VC, Lin NL. AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl. Cytokine 2004; 25: 52-60.
-
(2004)
Cytokine
, vol.25
, pp. 52-60
-
-
Broudy, V.C.1
Lin, N.L.2
-
26
-
-
62549153611
-
Preclinical activity of eltrombopag (SB-497115), an oral, non-peptide thrombopoietin receptor agonist
-
Erickson-Miller CL, Delorme E, Tian SS, Hopson CB, Landis AJ, Valoret EI, Sellers TS, Rosen J, Miller SG, Luengo JI, Duffy KJ, Jenkins JM. Preclinical activity of eltrombopag (SB-497115), an oral, non-peptide thrombopoietin receptor agonist. Stem Cells 2009; 27: 424-30.
-
(2009)
Stem Cells
, vol.27
, pp. 424-430
-
-
Erickson-Miller, C.L.1
Delorme, E.2
Tian, S.S.3
Hopson, C.B.4
Landis, A.J.5
Valoret, E.I.6
Sellers, T.S.7
Rosen, J.8
Miller, S.G.9
Luengo, J.I.10
Duffy, K.J.11
Jenkins, J.M.12
-
27
-
-
61349155417
-
AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist
-
Fukushima-Shintani M, Suzuki K, Iwatsuki Y, Abe M, Sugasawa K, Hirayama F, Kawasaki T, Nakahata T. AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist. Eur J Haematol 2009; 82: 247-54.
-
(2009)
Eur J Haematol
, vol.82
, pp. 247-254
-
-
Fukushima-Shintani, M.1
Suzuki, K.2
Iwatsuki, Y.3
Abe, M.4
Sugasawa, K.5
Hirayama, F.6
Kawasaki, T.7
Nakahata, T.8
-
28
-
-
34347210686
-
NMR structural studies of interactions of a small, nonpeptidyl Tpo mimic with the thrombopoietin receptor extracellular juxtamembrane and transmembrane domains
-
Kim MJ, Park SH, Opella SJ, Marsilje TH, Michellys PY, Seidel HM, Tian SS. NMR structural studies of interactions of a small, nonpeptidyl Tpo mimic with the thrombopoietin receptor extracellular juxtamembrane and transmembrane domains. J Biol Chem 2007; 282: 14253-61.
-
(2007)
J Biol Chem
, vol.282
, pp. 14253-14261
-
-
Kim, M.J.1
Park, S.H.2
Opella, S.J.3
Marsilje, T.H.4
Michellys, P.Y.5
Seidel, H.M.6
Tian, S.S.7
-
29
-
-
0027081704
-
Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis
-
Tremolada F, Casarin C, Alberti A, Drago C, Tagger A, Ribero ML, Realdi G. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol 1992; 16: 273-81.
-
(1992)
J Hepatol
, vol.16
, pp. 273-281
-
-
Tremolada, F.1
Casarin, C.2
Alberti, A.3
Drago, C.4
Tagger, A.5
Ribero, M.L.6
Realdi, G.7
-
30
-
-
0034983754
-
Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis
-
Adinolfi LE, Giordano MG, Andreana A, Tripodi MF, Utili R, Cesaro G, Ragone E, Durante Mangoni E, Ruggiero G. Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis. Br J Haematol 2001; 113: 590-5.
-
(2001)
Br J Haematol
, vol.113
, pp. 590-595
-
-
Adinolfi, L.E.1
Giordano, M.G.2
Andreana, A.3
Tripodi, M.F.4
Utili, R.5
Cesaro, G.6
Ragone, E.7
Durante Mangoni, E.8
Ruggiero, G.9
-
31
-
-
21344460746
-
The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis
-
Rios R, Sangro B, Herrero I, Quiroga J, Prieto J. The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis. Am J Gastroenterol 2005; 100: 1311-16.
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 1311-1316
-
-
Rios, R.1
Sangro, B.2
Herrero, I.3
Quiroga, J.4
Prieto, J.5
-
32
-
-
36549047972
-
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C
-
McHutchison JG, Dusheiko G, Shiffman ML, Rodriguez-Torres M, Sigal S, Bourliere M, Berg T, Gordon SC, Campbell FM, Theodore D, Blackman N, Jenkins J, Afdhal NH. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N Engl J Med 2007; 357: 2227-36.
-
(2007)
N Engl J Med
, vol.357
, pp. 2227-2236
-
-
McHutchison, J.G.1
Dusheiko, G.2
Shiffman, M.L.3
Rodriguez-Torres, M.4
Sigal, S.5
Bourliere, M.6
Berg, T.7
Gordon, S.C.8
Campbell, F.M.9
Theodore, D.10
Blackman, N.11
Jenkins, J.12
Afdhal, N.H.13
-
33
-
-
34247646400
-
The incidence and impact of thrombocytopenia in myelodysplastic syndromes
-
Kantarjian H, Giles F, List A, Lyons R, Sekeres MA, Pierce S, Deuson R, Leveque J. The incidence and impact of thrombocytopenia in myelodysplastic syndromes. Cancer 2007, 109: 1705-1714
-
(2007)
Cancer
, vol.109
, pp. 1705-1714
-
-
Kantarjian, H.1
Giles, F.2
List, A.3
Lyons, R.4
Sekeres, M.A.5
Pierce, S.6
Deuson, R.7
Leveque, J.8
-
34
-
-
37149046846
-
Evaluating safety and efficacy of AMG 531 for the treatment of thrombocytopenic patients with myelodysplastic syndrome (MDS): Preliminary results of a phase 1/2 study
-
[ASCO Annual Meeting Abstracts]
-
Kantarjian HM, Giles FJ, Fenaux P, Becker PS, Boruchov AM, Bowen DT, Hellström-Lindberg E, Larson RA, Lyons RM, Muus P. Evaluating safety and efficacy of AMG 531 for the treatment of thrombocytopenic patients with myelodysplastic syndrome (MDS): Preliminary results of a phase 1/2 study [ASCO Annual Meeting Abstracts]. J Clin Oncol 2007; 25 (Suppl. 18): 7032.
-
(2007)
J Clin Oncol
, vol.25
, Issue.SUPPL. 18
, pp. 7032
-
-
Kantarjian, H.M.1
Giles, F.J.2
Fenaux, P.3
Becker, P.S.4
Boruchov, A.M.5
Bowen, D.T.6
Hellström-Lindberg, E.7
Larson, R.A.8
Lyons, R.M.9
Muus, P.10
-
35
-
-
66749128758
-
Effect of romiplostim in patients (pts) with low or intermediate risk myelodysplastic syndrome (MDS) receiving Azacytidine [ASH Annual Meeting Abstracts]
-
Kantarjian H, Giles F, Greenberg P, Paquette R, Wang E, Gabrilove J, Garcia-Manero G, Gray J, Hu K, Franklin J. Effect of romiplostim in patients (pts) with low or intermediate risk myelodysplastic syndrome (MDS) receiving Azacytidine [ASH Annual Meeting Abstracts]. Blood 2008; 112: 224.
-
(2008)
Blood
, vol.112
, pp. 224
-
-
Kantarjian, H.1
Giles, F.2
Greenberg, P.3
Paquette, R.4
Wang, E.5
Gabrilove, J.6
Garcia-Manero, G.7
Gray, J.8
Hu, K.9
Franklin, J.10
-
36
-
-
33747339258
-
Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: Associations with impaired platelet production and increased platelet turnover
-
Yamazaki R, Kuwana M, Mori T, Okazaki Y, Kawakami Y, Ikeda Y, Okamoto S. Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: Associations with impaired platelet production and increased platelet turnover. Bone Marrow Transplant 2006; 38: 377-84.
-
(2006)
Bone Marrow Transplant
, vol.38
, pp. 377-384
-
-
Yamazaki, R.1
Kuwana, M.2
Mori, T.3
Okazaki, Y.4
Kawakami, Y.5
Ikeda, Y.6
Okamoto, S.7
-
37
-
-
9344225757
-
Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists
-
Oda A, Miyakawa Y, Druker BJ, Ozaki K, Yabusaki K, Shirasawa Y, Handa M, Kato T, Miyazaki H, Shimosaka A, Ikeda Y. Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists. Blood 1996; 87: 4664-70.
-
(1996)
Blood
, vol.87
, pp. 4664-4670
-
-
Oda, A.1
Miyakawa, Y.2
Druker, B.J.3
Ozaki, K.4
Yabusaki, K.5
Shirasawa, Y.6
Handa, M.7
Kato, T.8
Miyazaki, H.9
Shimosaka, A.10
Ikeda, Y.11
-
38
-
-
0032695763
-
Thrombopoietin-induced signal transduction and potentiation of platelet activation
-
Oda A, Miyakawa Y, Druker BJ, Ozaki K, Ohashi H, Kato T, Miyazaki H, Handa M, Ikebuchi K, Ikeda Y. Thrombopoietin-induced signal transduction and potentiation of platelet activation. Thromb Haemost 1999; 82: 377-84.
-
(1999)
Thromb Haemost
, vol.82
, pp. 377-384
-
-
Oda, A.1
Miyakawa, Y.2
Druker, B.J.3
Ozaki, K.4
Ohashi, H.5
Kato, T.6
Miyazaki, H.7
Handa, M.8
Ikebuchi, K.9
Ikeda, Y.10
-
39
-
-
0030945262
-
Thrombopoietin and thrombin induce tyrosine phosphorylation of Vav in human blood platelets
-
Miyakawa Y, Oda A, Druker BJ, Ozaki K, Handa M, Ohashi H, Ikeda Y. Thrombopoietin and thrombin induce tyrosine phosphorylation of Vav in human blood platelets. Blood 1997; 89: 2789-98.
-
(1997)
Blood
, vol.89
, pp. 2789-2798
-
-
Miyakawa, Y.1
Oda, A.2
Druker, B.J.3
Ozaki, K.4
Handa, M.5
Ohashi, H.6
Ikeda, Y.7
-
40
-
-
10544225380
-
Crkl is constitutively tyrosine phosphorylated in platelets from chronic myelogenous leukemia patients and inducibly phosphorylated in normal platelets stimulated by thrombopoietin
-
Oda A, Miyakawa Y, Druker BJ, Ishida A, Ozaki K, Ohashi H, Wakui M, Handa M, Watanabe K, Okamoto S, Ikeda Y. Crkl is constitutively tyrosine phosphorylated in platelets from chronic myelogenous leukemia patients and inducibly phosphorylated in normal platelets stimulated by thrombopoietin. Blood 1996; 88: 4304-13.
-
(1996)
Blood
, vol.88
, pp. 4304-4313
-
-
Oda, A.1
Miyakawa, Y.2
Druker, B.J.3
Ishida, A.4
Ozaki, K.5
Ohashi, H.6
Wakui, M.7
Handa, M.8
Watanabe, K.9
Okamoto, S.10
Ikeda, Y.11
-
41
-
-
0030052617
-
Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets
-
Miyakawa Y, Oda A, Druker BJ, Miyazaki H, Handa M, Ohashi H, Ikeda Y. Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets. Blood 1996; 87: 439-46.
-
(1996)
Blood
, vol.87
, pp. 439-446
-
-
Miyakawa, Y.1
Oda, A.2
Druker, B.J.3
Miyazaki, H.4
Handa, M.5
Ohashi, H.6
Ikeda, Y.7
-
42
-
-
0029052479
-
Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and Shc in human blood platelets
-
Miyakawa Y, Oda A, Druker BJ, Kato T, Miyazaki H, Handa M, Ikeda Y. Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and Shc in human blood platelets. Blood 1995; 86: 23-7.
-
(1995)
Blood
, vol.86
, pp. 23-27
-
-
Miyakawa, Y.1
Oda, A.2
Druker, B.J.3
Kato, T.4
Miyazaki, H.5
Handa, M.6
Ikeda, Y.7
-
43
-
-
36749001043
-
Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells
-
Qian H, Buza-Vidas N, Hyland CD, Jensen CT, Antonchuk J, Månsson R, Thoren LA, Ekblom M, Alexander WS, Jacobsen SE. Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell 2007; 1: 671-84.
-
(2007)
Cell Stem Cell
, vol.1
, pp. 671-684
-
-
Qian, H.1
Buza-Vidas, N.2
Hyland, C.D.3
Jensen, C.T.4
Antonchuk, J.5
Månsson, R.6
Thoren, L.A.7
Ekblom, M.8
Alexander, W.S.9
Jacobsen, S.E.10
-
44
-
-
36748999351
-
Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche
-
Yoshihara H, Arai F, Hosokawa K, Hagiwara T, Takubo K, Nakamura Y, Gomei Y, Iwasaki H, Matsuoka S, Miyamoto K, Miyazaki H, Takahashi T, Suda T. Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell 2007; 1: 685-97.
-
(2007)
Cell Stem Cell
, vol.1
, pp. 685-697
-
-
Yoshihara, H.1
Arai, F.2
Hosokawa, K.3
Hagiwara, T.4
Takubo, K.5
Nakamura, Y.6
Gomei, Y.7
Iwasaki, H.8
Matsuoka, S.9
Miyamoto, K.10
Miyazaki, H.11
Takahashi, T.12
Suda, T.13
-
45
-
-
66749122752
-
Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia
-
Kuter DJ. Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia. Annu Rev Med 2009; 60: 193-206.
-
(2009)
Annu Rev Med
, vol.60
, pp. 193-206
-
-
Kuter, D.J.1
-
46
-
-
18344410760
-
NOD/SCID/gamma(c) (null) mouse: An excellent recipient mouse model for engraftment of human cells
-
Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K, Heike T, Nakahata T. NOD/SCID/gamma(c) (null) mouse: An excellent recipient mouse model for engraftment of human cells. Blood 2002; 100: 3175-82.
-
(2002)
Blood
, vol.100
, pp. 3175-3182
-
-
Ito, M.1
Hiramatsu, H.2
Kobayashi, K.3
Suzue, K.4
Kawahata, M.5
Hioki, K.6
Ueyama, Y.7
Koyanagi, Y.8
Sugamura, K.9
Tsuji, K.10
Heike, T.11
Nakahata, T.12
-
47
-
-
50949114155
-
Interferon-alpha 2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes
-
Yamane A, Nakamura T, Suzuki H, Ito M, Ohnishi Y, Ikeda Y, Miyakawa Y. Interferon-alpha 2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes. Blood 2008; 112: 542-50.
-
(2008)
Blood
, vol.112
, pp. 542-550
-
-
Yamane, A.1
Nakamura, T.2
Suzuki, H.3
Ito, M.4
Ohnishi, Y.5
Ikeda, Y.6
Miyakawa, Y.7
|